Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG: 0874)

Guangzhou Baiyunshan Pharmaceutical Holdings Company Statistics

Total Valuation

Guangzhou Baiyunshan Pharmaceutical Holdings Company has a market cap or net worth of HKD 47.83 billion. The enterprise value is 46.02 billion.

Market Cap	47.83B
Enterprise Value	46.02B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Oct 15, 2024

Share Statistics

Guangzhou Baiyunshan Pharmaceutical Holdings Company has 1.63 billion shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	n/a
Shares Outstanding	1.63B
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	18.80%
Float	876.22M

Valuation Ratios

The trailing PE ratio is 7.75 and the forward PE ratio is 7.44.

PE Ratio	7.75
Forward PE	7.44
PS Ratio	0.35
PB Ratio	0.73
P/TBV Ratio	n/a
P/FCF Ratio	22.73
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.55, with an EV/FCF ratio of 35.59.

EV / Earnings	12.14
EV / Sales	0.54
EV / EBITDA	8.55
EV / EBIT	10.63
EV / FCF	35.59

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.37.

Current Ratio	1.46
Quick Ratio	1.09
Debt / Equity	0.37
Debt / EBITDA	2.88
Debt / FCF	12.00
Interest Coverage	9.08

Financial Efficiency

Return on equity (ROE) is 9.73% and return on invested capital (ROIC) is 4.85%.

Return on Equity (ROE)	9.73%
Return on Assets (ROA)	3.18%
Return on Capital (ROIC)	4.85%
Revenue Per Employee	3.02M
Profits Per Employee	135,192
Employee Count	28,048
Asset Turnover	0.99
Inventory Turnover	6.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.59% in the last 52 weeks. The beta is 0.55, so Guangzhou Baiyunshan Pharmaceutical Holdings Company's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	-11.59%
50-Day Moving Average	18.78
200-Day Moving Average	20.17
Relative Strength Index (RSI)	39.93
Average Volume (20 Days)	1,868,267

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of HKD 84.61 billion and earned 3.79 billion in profits. Earnings per share was 2.33.

Revenue	84.61B
Gross Profit	14.32B
Operating Income	4.33B
Pretax Income	4.83B
Net Income	3.79B
EBITDA	5.09B
EBIT	4.33B
Earnings Per Share (EPS)	2.33

Balance Sheet

The company has 19.35 billion in cash and 15.52 billion in debt, giving a net cash position of 3.84 billion or 2.36 per share.

Cash & Cash Equivalents	19.35B
Total Debt	15.52B
Net Cash	3.84B
Net Cash Per Share	2.36
Equity (Book Value)	42.15B
Book Value Per Share	24.68
Working Capital	18.60B

Cash Flow

In the last 12 months, operating cash flow was 2.71 billion and capital expenditures -1.42 billion, giving a free cash flow of 1.29 billion.

Operating Cash Flow	2.71B
Capital Expenditures	-1.42B
Free Cash Flow	1.29B
FCF Per Share	0.80

Margins

Gross margin is 16.92%, with operating and profit margins of 5.12% and 4.48%.

Gross Margin	16.92%
Operating Margin	5.12%
Pretax Margin	5.71%
Profit Margin	4.48%
EBITDA Margin	6.01%
EBIT Margin	5.12%
FCF Margin	1.53%

Dividends & Yields

This stock pays an annual dividend of 0.86, which amounts to a dividend yield of 4.74%.

Dividend Per Share	0.86
Dividend Yield	4.74%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	6
Payout Ratio	46.58%
Buyback Yield	-0.01%
Shareholder Yield	4.73%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Guangzhou Baiyunshan Pharmaceutical Holdings Company has an Altman Z-Score of 2.48. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.48
Piotroski F-Score	n/a